Company recalls over 541,000 winter tires because they don’t have enough snow traction
DETROIT (AP) — A company that sells replacement winter tires is recalling more than 541,000 of them in the U.S. because they don’t have enough snow traction to meet North American standards.
Prinx Chengshan Tire North America is recalling over 100 sizes of Fortune Tormenta and Prinx Hicountry tires with three-peak mountain snowflake symbols on the sidewalls.
The company says in documents posted Tuesday by the National Highway Traffic Safety Administration that the tires passed European tests but likely would not meet traction standards in North America.
The safety agency says tires without sufficient snow traction can increase the risk of a crash.
Prinx Chengshan is working on a way to fix the problem. Owners will be notified by letter starting Feb. 1. Those with questions can call the company at (310) 205-8355, extension 109.
More Stories
Beyond Algorithmic Echo Chambers: The Rise of Authentic Lifestyle Communities in Europe’s Creator Economy
Europe’s social media landscape is undergoing a quiet revolution. After more than a decade of polished influencer culture, algorithmic homogenization,...
What UK SMEs Should Know About Workplace EV Charging
A workplace EV charge point used to be a perk reserved for headquartered corporates. The picture in 2026 looks different....
Apprenticeships ‘tougher to land than Oxbridge places’ as ministers pledge £600m for 60,000 new starts
In a claim that will resonate with thousands of school-leavers wading through a torrent of rejection emails this summer, the...
Farage promises tax-free overtime in £5bn pitch to working Britain
Reform UK leader vows to lift income tax from overtime pay for anyone earning under £75,000, a policy he says...
Overseas investors retreat from UK commercial property as red tape bites
Britain’s pitch as the most reliable address in European real estate has taken a knock. Foreign investors, the lifeblood of...
Alvotech founder Robert Wessman threatens to quit Britain over ‘anti-wealth’ tax regime
The Icelandic-born billionaire behind Nasdaq-listed biosimilars group Alvotech has become the latest international entrepreneur to warn that Britain’s tax direction...